NCM · Medical - Diagnostics & Research

Intelligent Bio Solutions Inc. (INBS) Stock

$1.53 -2.55% NCM: INBS Healthcare

Valuation

MetricValue
Price$1.53
Market Cap$5.07M
P/E Ratio-0.18
P/B Ratio0.88
P/S Ratio1.31
EPS (TTM)$-20.00
52-Week High$24.90
52-Week Low$1.52
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-170.36%
ROA-104.10%
ROCE-183.34%
Gross Margin-366.67%
Operating Margin-366.67%
Net Margin-294.91%
Debt/Equity0.33
Current Ratio0.80

Annual Financials (USD)

Metric20222023202420252026
Revenue$0$1.0M$3.0M$3.0M$4.0M
Operating Profit$-8.0M$-13.0M$-10.0M$-11.0M$-13.0M
Net Profit$-8.0M$-11.0M$-10.0M$-11.0M$-12.0M
EPS$-113.30$-105.80$-63.80$-20.00$-8.44
Op Margin—-1002.1%-330.5%-348.7%-299.1%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$12.0M$10.0M$14.0M$8.0M$12.0M
Total Liabilities$6.0M$7.0M$6.0M$5.0M$7.0M
Cash$8.0M$2.0M$6.0M$1.0M$4.0M
Borrowings$0$2.0M$1.0M$0$2.0M

Latest News

Intelligent Bio Solutions Launches FDA Interference Study for Fingerprinting Drug Test System MT Newswires · Jun 16, 2026 Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry GlobeNewswire · Jun 16, 2026 Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18 GlobeNewswire · Jun 4, 2026 Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission GlobeNewswire · Jun 2, 2026 Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year GlobeNewswire · May 13, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$-3.0M$-7.0M$-10.0M$-10.0M$-12.0M
Investing Cash Flow$-1.0M$-1.0M$0$0$0
Financing Cash Flow$0$-1.0M$2.0M$0$0
Net Cash Flow$-4.0M$-7.0M$5.0M$-5.0M$3.0M
Free Cash Flow$-4.0M$-8.0M$-10.0M$-10.0M$-12.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.29
FCF Yield-221.66%
Quick Ratio1.35
Interest Coverage-190.05
Return 1Y-87.95%
Return 3Y-99.36%
Return 5Y-99.97%

Ownership

Insiders Held3.57%
Institutions Held8.71%
Institutions Float Held9.03%
Institutional HolderSharesReport Date
Armistice Capital, LLC130,0002026-03-31
Alyeska Investment Group, L.p.37,9562026-03-31
Geode Capital Management, LLC28,6092026-03-31
Vanguard Capital Management LLC5,8102026-03-31
Vanguard Fiduciary Trust Co3,9582026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADILAdial Pharmaceuticals, Inc $3.90 -1.76% -0.26 $10.24M 0.00%
BCLIBrainstorm Cell Therapeutics Inc. $0.98 +6.52% -1.04 $10.81M 0.00%
BNGOBionano Genomics, Inc. $1.44 -1.71% -0.45 $16.47M 0.00%
CHEKCheck-Cap Ltd. $1.86 +1.64% -0.43 $10.88M 0.00%
HSCSHeartSciences Inc. $3.18 +4.61% -1.36 $6.87M 0.00%

About Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc. is led by CEO Harry Simeonidis, employs 50 people, headquartered in US, publicly traded since 2020.

Intelligent Bio Solutions Inc. (INBS) stock trades at $1.53 with a market capitalization of $5.07M. The stock is valued at a price-to-earnings (P/E) ratio of -0.18, price-to-book of 0.88, price-to-sales of 1.31. Over the past 52 weeks the stock has ranged between $1.52 and $24.90, and currently trades 93.9% below its 52-week high.

On profitability, Intelligent Bio Solutions Inc. generates a return on equity (ROE) of -170.36%, return on capital employed of -183.34%, an operating margin of -366.67%, a net profit margin of -294.91%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides